University of Thessaly (UTH)
Μελέτη προγνωστικών και προβλεπτικών παραγόντων καρκίνου της ουροδόχου κύστης: διερεύνηση των συστημάτων NEP/νευροπεπτιδίων και ουβικουιτίνης/ πρωτεασώματος/NFκΒ
Abstract
dc:descriptionThe neutral endopeptidase (NEP/CD10)-neuropeptides (such as endothelin 1/ET-1) axis and the molecular pathway of the transcriptional nuclear factor kappaB (NFκB)-ubiquitin-proteasome are two mechanisms which have associated, independently from one another, with urinary bladder cancer. We studied these biological pathways as well as the relationship between them, using archived biological material (paraffin embedded tissue from transurethral resections of bladder tumors and radical cystectomies), in two groups of patients with bladder cancer. We prospectively studied patients with muscle-invasive bladder cancer and we retrospectively studied patients with non-muscle-invasive, high-grade bladder cancer. Finally, we performed immunohistochemical study for the following biological markers: NEP/CD10, ET-1 and NFκB (cytoplasmic).Our research hypothesis is that these two pathways are directly connected and interact in bladder cancer. Therefore, the neuropeptides could stimulate and activate the inactive cytoplasmic form of NFκB, resulting to its transfer into the nucleus (analogue mechanism of action with the extracellular stimulators of NFκB). As representative neuropeptide for testing our hypothesis we picked ET-1. If our hypothesis is correct, then the following should be proved: ↓ levels and/or activity of CD10 ► ↑ levels and activity of ΕΤ-1 ( ► ↑ cell proliferation, ↓ apoptosis and ↑ neovascularization ► negative clinical outcome in bladder cancer) ► ↑ proteasome activity ► ↑ proteasomal degradation IκB ► ↑ activity ΙΚΚ ► ↑ transcriptional activity of NF-κB ► ↑ NF-κB-dependent factors of angiogenesis, infiltration and metastasis ► negative clinical outcome in bladder cancer. Muscle-invasive bladder cancer patients:Only overexpression of ET-1 was significantly associated with negative clinical outcome, specifically with an increased hazard ratio for disease progression, in comparison with patients with mild expression of ET-1, throughout the duration of the monitoring period. Additionally, it was significantly associated with negative clinical outcome, specifically with an increased hazard ratio for death, in comparison with patients with moderate expression of ET-1, throughout the duration of the monitoring period. Finally, it was significantly associated with negative clinical outcome, specifically with an increased hazard ratio for death, in comparison with patients with mild expression of ET-1, throughout the duration of the monitoring period.Non-muscle invasive high grade bladder cancer patients:Expression of ET-1 was significantly associated with negative clinical outcome, specifically with an increased odds ratio for recurrence as well as progression of the disease and additionally with an increased hazard ratio for disease recurrence.Expression of NFκB was significantly associated with negative clinical outcome, specifically with an increased odds ratio for disease progression but not for recurrence.Muscle-invasive and non-muscle invasive high grade bladder cancer patients:Expression of NEP/CD10 was not associated with the studied prognostic parameters.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mitrakas, Lampros
- Μητράκας, Λάμπρος
Subjects
dc:subject × 6Rights
dc:rights- Statement dc:rights
-
- BY_NC
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35299